Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2528-2534

  Qian, Y M ^a   Qin, X ^a   Miwa, T ^a   Sun, X ^a   Halperin, J A ^a   Song, W C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT INHIBITOR; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CHO CELL; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC ANALYSIS; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0034283946     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2528     Document Type: Article

References (42)

1. Membrane proteins that protect against complement lysis
2. The regulators of complement activation (RCA) gene cluster
3. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes
4. CD59, an Ly-6-like protein expressed in human lymphoid-cells, regulates the action of the complement membrane attack complex on homologous cells
5. Human protectin (CD59), an 18,000-20,000 MW complement lysis restriction factor, inhibits C5b-8 catalyzed insertion of C9 into lipid bilayers
6. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9
7. 20 kd Homologous restriction factor of complement resembles T-cell activating protein
8. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
9. Paroxysmal nocturnal haemoglobinuria
10. Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria
11. Isolation and characterization of a membrane-protein from normal human-erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria
12. Inherited complement deficiency of 20-kilodalton homologous restriction factor (cD59) as a cause of paroxysmal nocturnal hemoglobinuria
13. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein decay-accelerating factor
14. Structure of the CD59-encoding gene: Further evidence of a relationship to mufine lymphocyte antigen LY-6 protein
15. Gene structure of human CD59 and demonstration that discrete messenger-RNAs are generated by alternative polyadenylation
16. Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59): Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter
17. Contribution of the N-linked carbohydrate antigen CD59 to its complement-inhibitory activity
18. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59
19. Colocalization of the human CD59 gene to 11p13 with the MIC11 cell surface antigen
20. Molecular cloning of the rat analog of human CD59 and identification of a putative active site
21. Molecular cloning, chromosomal localization, expression and functional characterization of the mouse analogue of human CD59
22. Molecular cloning and functional characterization of the pig analogue of CD59: Relevance to xenotransplantation
23. Molecular characterization of a testis-specific estrogen sulfotransferase and aberrant expression in obese and diabetogenic C57BL/KSJ-db/db mice
24. Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59
25. Transfected CD59 protects mesangial cells from injury induced by antibody and complement
26. Isolation and expression of the full-length cDNA encoding CD59 antigen of human lymphocytes
27. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells
28. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells
29. Molecular basis for a link between complement and the vascular complications of diabetes
30. Glycolipid anchoring of plasma membrane proteins
31. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms
32. Mouse decay-accelerating factor, selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidyli-nositol-anchored form
33. Structure of the gene for human-complement protein decay-accelerating factor
34. Characterization of the decay-accelerating factor gene promoter region
35. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55)
36. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis
37. Membrane attack complex (MAC) mediated damage to spermatozoa: Protection of the cells by the presence on their membranes of MAC inhibitory proteins
38. Several vascular complement inhibitors are present on human sperm
39. Evaluation of antisperm complement-dependent immune mediators in human ovarian follicular fluid
40. The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies